Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory Small Cell Lung Cancer
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2019.06.021
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Elsevier BV